How to buy Vertex Pharmaceuticals shares

Learn how to easily invest in Vertex Pharmaceuticals shares.

Vertex Pharmaceuticals Inc (VRTX) is a publicly traded biotechnology business based in the US which employs around 5,400 staff. Vertex Pharmaceuticals is listed on the NASDAQ and traded in US dollars. Its current price of $473.98 is 2.4% up on its price a month ago ($462.99).

How to buy shares in Vertex Pharmaceuticals

  1. Open a brokerage account. Choose from our top broker picks or compare brokers in depth. Then, complete an application.
  2. Fund your account. Add money to your account via bank transfer, debit card or credit card.
  3. Search the platform by ticker symbol. VRTX in this case.
  4. Choose an order type. Place a market order or limit order with your preferred number of shares or dollar amount.
  5. Submit the order. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Our top picks for where to buy Vertex Pharmaceuticals shares

Best for 0% commission stocks
eToro Free Stocks logo
Finder Award
Go to site
Capital at risk. Fees apply.
Copy picks from top traders
4.3 ★★★★★
Commission-free trades
Fractional shares
Get dividend payments
Best for fractional shares
XTB logo
Go to site
Capital at risk. T&Cs apply.
Earn 4.75% on uninvested funds
4.4 ★★★★★
Commission-free trades
Fractional shares
5,400+ stocks/ETFs
Best for US shares
CMC Invest share dealing account logo
Finder Award
Go to site
Capital at risk. T&Cs apply.
Try Plus free for 3 months
4.4 ★★★★★
Commission-free trades
3,000+ stocks
Real-time live pricing

Fees calculator for buying Vertex Pharmaceuticals shares with popular apps

Both exchange rates and share prices fluctuate in real time, so the costs estimated here should be considered as a guide only. They don't factor in spreads, which can be hard to pin down. Always refer to the platform itself for availability and pricing.

Quantity of shares

2
Platform Finder Score Account fee Min. initial deposit Trade cost Link
eToro Free Stocks logo
4.3 ★★★★★
£0 $100 £750.11
Go to siteCapital at risk
Freetrade logo
4.4 ★★★★★
£0 £1 £751.90
Go to siteCapital at risk
XTB logo
4.4 ★★★★★
£0 £0 £748.25
Go to siteCapital at risk
CMC Invest share dealing account logo
4.4 ★★★★★
£0 £0 £748.25
Go to siteCapital at risk
Hargreaves Lansdown Fund and Share Account logo
4.2 ★★★★★
£0 (0.45% for funds) £1 £763.92
Go to siteCapital at risk

Full comparison of share dealing platforms

These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.


Alternative ways to invest in Vertex Pharmaceuticals

Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Vertex Pharmaceuticals), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.

Vertex Pharmaceuticals is a major part of the NASDAQ, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).

ETF5-year performance (to August 2024)Link to invest
Invesco S&P 500 (SPXP)Invesco icon94.07%Invest with XTBCapital at risk
Xtrackers S&P 500 Swap (XSPX)DWS Xtrackers icon93.77%Invest with XTBCapital at risk
iShares Core S&P 500 (CSP1)iShares icon91.84%Invest with XTBCapital at risk
HSBC S&P 500 (HSPX)HSBC icon80.38%Invest with XTBCapital at risk
Vanguard S&P 500 (VUSA)Vanguard icon79.29%Invest with XTBCapital at risk
SPDR S&P 500 ETF (SPX5)SPDR icon79.17%Invest with XTBCapital at risk

Is it a good time to buy Vertex Pharmaceuticals stock?

Review technicals and fundamentals to help you determine if now's a good time for you to invest.

Technical analysis

View Vertex Pharmaceuticals's price performance, share price volatility, historical data and technicals.

Use our graph to track the performance of VRTX stock over time.

Historical closes compared with the last close of $473.98

1 week (2024-12-02) -4.96%
1 month (2024-11-09) 2.37%
3 months (2024-09-09) -4.30%
6 months (2024-06-09) 19.25%
1 year (2023-12-09) 30.56%
2 years (2022-12-09) 53.29%
3 years (2021-12-09) 156.22%
5 years (2019-12-09) 143.70%

The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Promoted
eToro Free Stocks
Invest in Vertex Pharmaceuticals shares
Finder AwardFree Trades
  • Over 5,500+ stocks from 20 exchanges
  • Free to open an account
  • Commission-free trading

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.


Is Vertex Pharmaceuticals under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Vertex Pharmaceuticals P/E ratio, PEG ratio and EBITDA.

Vertex Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Vertex Pharmaceuticals's shares trade at around 0x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of November 09, 2023 (20.44). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Vertex Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.5621. A PEG ratio below 1 can be interpreted as meaning the shares are not overvalued given the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Vertex Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Vertex Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $4.4 billion (£3.5 billion).

The EBITDA is a measure of Vertex Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.


More guides on Finder

  • How to buy Canopy Growth shares

    Ever wondered how to buy shares in Canopy Growth? We explain how and compare a range of providers that can give you access to many brands, including Canopy Growth.

  • How to buy Green Thumb Industries shares

    Ever wondered how to buy shares in Green Thumb Industries? We explain how and compare a range of providers that can give you access to many brands, including Green Thumb Industries.

  • How to buy Curaleaf Holdings shares

    Ever wondered how to buy shares in Curaleaf Holdings? We explain how and compare a range of providers that can give you access to many brands, including Curaleaf Holdings.

  • How to buy Genesis Healthcare shares

    Ever wondered how to buy shares in Genesis Healthcare? We explain how and compare a range of providers that can give you access to many brands, including Genesis Healthcare.

  • How to buy Allergy Therapeutics shares

    Ever wondered how to buy shares in Allergy Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Allergy Therapeutics.

  • How to buy 4D pharma shares

    Ever wondered how to buy shares in 4D pharma? We explain how and compare a range of providers that can give you access to many brands, including 4D pharma.

  • How to buy Aurora Cannabis shares

    Ever wondered how to buy shares in Aurora Cannabis? We explain how and compare a range of providers that can give you access to many brands, including Aurora Cannabis.

  • How to buy Evgen Pharma shares

    Thinking about buying shares in Evgen Pharma? We explain how to do it and compare a range of providers who will give you access to global markets.

  • How to buy Intuitive Surgical shares

    Ever wondered how to buy shares in Intuitive Surgical? We explain how and compare a range of providers that can give you access to many brands, including Intuitive Surgical.

  • How to buy Stryker Corporation shares

    Ever wondered how to buy shares in Stryker? We explain how and compare a range of providers that can give you access to many brands, including Stryker.

Go to site